GLP-3 10MG
Unlock the future of metabolic research with GLP-3 10MG Vial, a premium lyophilized powder engineered as a triple agonist targeting GLP-1, GIP, and glucagon receptors. This high-purity (>99%) research-grade peptide, delivered in a 3mL glass vial as a pristine white powder, empowers scientists to explore groundbreaking pathways in energy balance, glucose homeostasis, and weight management models. With its potent molecular formula C223H343F3N46O70 and molecular weight of approximately 4845.44 g/mol, GLP-3 offers unparalleled precision for in vitro studies on metabolic regulation, insulin sensitivity, and hepatic function. Reconstitute effortlessly for cutting-edge experiments—exclusively for laboratory use.
$186.25
đźšš Free shipping on all orders (US Only )
🔄 All sales are final
FDA Disclaimer:Â The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.
Overview
– **Triple Agonist Power:** Simultaneously activates GLP-1, GIP, and glucagon receptors for comprehensive metabolic pathway exploration.
– **Superior Purity and Stability:** >99% purity lyophilized powder in a 3mL vial, ensuring reliable results in demanding lab conditions.
– **Weight Management Insights:** Enables studies on substantial, dose-dependent weight loss and long-term maintenance.
– **Metabolic Optimization:** Supports research into glycemic control, insulin sensitivity, lipid profiles, and liver fat reduction.
– **Research-Ready Design:** White lyophilized powder with easy reconstitution for precise in vitro applications.
Structure
GLP-3 is a synthetic 39-amino-acid peptide with the sequence YA1QGTFTSDYSIL2LDKK4AQA1AFIEYLLEGGPSSGAPPPS3, featuring key modifications including fluorinated residues for enhanced stability. Its molecular formula, C223H343F3N46O70, yields a molecular weight of 4845.44 g/mol (or variants ~4731 g/mol free base), with CAS 2381089-83-2. This structure enables potent, balanced activation across GLP-1, GIP, and glucagon receptors, mimicking incretin and glucagon signaling for multi-pathway metabolic studies.
Research
GLP-3 represents a breakthrough in peptide research, functioning as a triple hormone receptor agonist that integrates GLP-1, GIP, and glucagon signaling pathways to modulate energy homeostasis, appetite regulation, and nutrient metabolism. In laboratory models, it drives substantial weight reduction, enhances insulin sensitivity, improves glycemic control, and reduces liver fat accumulation while optimizing lipid profiles and cardiovascular markers. This multi-target mechanism unlocks novel insights into obesity, type 2 diabetes, and metabolic syndrome, with once-weekly dosing potential for sustained effects—ideal for in vitro exploration of redox balance, mitochondrial efficiency, and adaptive stress responses.
Referenced Citations
Nexxgen Peptides. (n.d.). *GLP-3 R10 mg lyophilized powder (research use only)*. Retrieved from https://nexxgenpeptides.com/product/glp-3-r10mg-lyophilized-powder-research-use-only-copy/
Revigen Research. (n.d.). *GLP-3 (Reta) 10mg*. Retrieved from https://revigenresearch.com/glp-3-reta-10mg/
Luvion Bio. (n.d.). *GLP-3 | Triple agonist | Premium RUO grade*. Retrieved from https://luvionbio.com/product/glp-3/
Biolongevity Labs. (n.d.). *GLP-3 (Retatrutide) – 10mg*. Retrieved from https://biolongevitylabs.com/product/glp-3-10mg/
Peptide Technologies. (n.d.). *GLP-3 “RT” 10mg*. Retrieved from https://peptidetech.co/product/glp-3-rt-10mg/